Cleared Traditional

K212618 - iRelieve Microcurrent Pain Relief System (FDA 510(k) Clearance)

Sep 2022
Decision
392d
Days
Class 2
Risk

K212618 is an FDA 510(k) clearance for the iRelieve Microcurrent Pain Relief System. This device is classified as a Stimulator, Nerve, Transcutaneous, For Pain Relief (Class II - Special Controls, product code GZJ).

Submitted by Fast Track Technologies, Inc. (Newport Beach, US). The FDA issued a Cleared decision on September 14, 2022, 392 days after receiving the submission on August 18, 2021.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5890.

Submission Details

510(k) Number K212618 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2021
Decision Date September 14, 2022
Days to Decision 392 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZJ - Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5890